NEWBRIDGE PHARMACEUTICALS
Newbridge Pharmaceuticals, a pharmaceutical, biologics, and medical device company, engages in the sale and marketing of healthcare products. It offers oncology and supportive care products, such as CLASTEON, a bisphosphonate, which treats problems associated with bone metastasis; SANCUSO, a granisetron transdermal system for the prevention of chemotherapy induced nausea and vomiting; and GLICONORM, a film-coated divisible tablet for the treatment of non-insulin dependent diabetes mellitus. The ... company provides therapeutic products for diseases, such as diabetes, obesity, oncology, and cardiovascular diseases, as well as for other metabolic disorders. It serves biotechnology and pharmaceutical companies in the Middle East, Africa, Turkey, and Caspian Regions. Newbridge Pharmaceuticals was founded in 2007 and is based in Dubai, the United Arab Emirates.
NEWBRIDGE PHARMACEUTICALS
Industry:
Biotechnology Medical Device Pharmaceutical
Founded:
2007-01-01
Address:
Dubai, Dubai, United Arab Emirates
Country:
United Arab Emirates
Website Url:
http://www.nbpharma.com
Total Employee:
51+
Status:
Active
Contact:
971 44298700
Email Addresses:
[email protected]
Total Funding:
60 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag Euro
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Founder
Investors List
Elan Corporation
Elan Corporation investment in Series C - NewBridge Pharmaceuticals
Kuwait Life Sciences Company
Kuwait Life Sciences Company investment in Series C - NewBridge Pharmaceuticals
Burrill & Company
Burrill & Company investment in Series C - NewBridge Pharmaceuticals
Kuwait Life Sciences Company
Kuwait Life Sciences Company investment in Series B - NewBridge Pharmaceuticals
Burrill & Company
Burrill & Company investment in Series B - NewBridge Pharmaceuticals
Official Site Inspections
http://www.nbpharma.com Semrush global rank: 7.83 M Semrush visits lastest month: 432
- Host name: 172.67.165.205
- IP address: 172.67.165.205
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
